Diagnos Laboratorium Utama PT Tbk Cash Flow Quality Index
Diagnos Laboratorium Utama PT Tbk cash flow quality index. Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow Quality Index of 3.53x as of June 2024. Operating cash flow of Rp3.32 Billion exceeds net income of Rp940.04 Million, indicating high earnings quality where cash backs reported profits. Explore DGNS debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Diagnos Laboratorium Utama PT Tbk (2017–2024)
Cash flow quality index of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024. Historical Cash Flow Quality Index for Diagnos Laboratorium Utama PT Tbk across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. See DGNS equity financing ratio to measure how much of total assets are equity-financed.
Diagnos Laboratorium Utama PT Tbk Cash Flow Quality Index by Year (2017–2024)
Diagnos Laboratorium Utama PT Tbk cash flow quality index by year from 2017 to 2024. Year-by-year earnings quality comparison for Diagnos Laboratorium Utama PT Tbk. For the full cash flow conversion analysis, see DGNS cash generation efficiency.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 36.52x | Rp27.30 Billion | Rp747.44 Million | ▲ +7788.8% |
| 2022 | -0.48x | Rp-6.02 Billion | Rp12.66 Billion | ▼ -151.9% |
| 2021 | 0.92x | Rp58.87 Billion | Rp64.30 Billion | ▲ +83.9% |
| 2020 | 0.50x | Rp26.23 Billion | Rp52.69 Billion | ▼ -58.8% |
| 2019 | 1.21x | Rp11.20 Billion | Rp9.27 Billion | ▲ +32.1% |
| 2018 | 0.91x | Rp8.47 Billion | Rp9.26 Billion | ▲ +277.4% |
| 2017 | -0.52x | Rp-712.00 Million | Rp1.38 Billion | — |